Cambridge Investment Research Advisors’s Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock STRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
16,997
-500
-3% -$40K ﹤0.01% 2003
2025
Q4
$1.38M Sell
17,497
-322
-2% -$27.7K ﹤0.01% 1847
2025
Q3
$1.63M Sell
17,819
-13,126
-42% -$1.37M ﹤0.01% 1661
2025
Q2
$3.75M Buy
30,945
+2,012
+7% +$192K 0.01% 1015
2025
Q1
$2.43M Buy
+28,933
New +$2.59M 0.01% 1223

Other funds holding STRK

Cambridge Investment Research Advisors's STRK Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock (STRK) stake by 2.9% in Q1 2026, selling an estimated $40K and leaving 16,997 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Cambridge Investment Research Advisors first reported a position in STRK in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.75M in Q2 2025. 92 funds tracked by Wall St. Rank hold STRK as of Q1 2026.

  • Cambridge Investment Research Advisors held 16,997 shares of Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock worth $1.2M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 500 Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock shares in Q1 2026, an estimated $40K.
  • Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2003 holding.
  • Cambridge Investment Research Advisors first reported a position in Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock in Q1 2025 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock position peaked at $3.75M in Q2 2025.
  • 92 funds tracked by Wall St. Rank held Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.